期刊文献+

脂质体佐剂对增强HBsAg免疫原性的作用 被引量:18

Liposome Adjuvant Enhances the Immunogenicity of Hepatitis B Vaccine
原文传递
导出
摘要 利用DC Chol制备粒径为 5 0~ 30 0nm的正电荷脂质体 ,作为乙肝疫苗 (HBsAg)的佐剂 ,免疫BALB/c小鼠后进行血清中特异性抗体IgG1及IgG2a、脾细胞产生细胞因子的检测。结果该脂质体佐剂所诱导的抗体亚类以IgG2a为主 ,脾细胞产生的IL 2、IL 5、IFN γ分别比铝佐剂组高 16 5倍、 10倍、 2倍。表明该脂质体佐剂可以诱导很强的细胞免疫反应 ,是一种能促进Th1和Th2均衡应答的佐剂 。 A cationic liposome (50~300 nm) was made by DC-Chol After mixing with hepatitis B vaccine (HBsAg),BALB/c mice was immunized and then examined the specific antibodies (IgG1 and IgG2a) and cytokines produced by murine splenic lymphocytes The results showed that antibodies produced by this mixture were mainly to be the IgG2a subclass IL-2,IL-5 and IFN-γ secreted in vitro by splenic lymphocytes with liposome-HBsAg were much higher than Al(OH) 3 -HBsAg Thus,the liposome was able to induce cellular immune response to HBsAg Furthermore,DC-Chol liposome could provide a signal to switch on both Th1 and Th2 responses However,it needs further investigation -
出处 《上海免疫学杂志》 CSCD 北大核心 2002年第6期395-397,共3页 Shanghai Journal of Immunology
关键词 脂质体佐剂 HBSAG 免疫原性 细胞免疫 乙型肝炎表面抗原 HBsAg cationic liposome adjuvant cellular immunity
  • 相关文献

参考文献7

  • 1[1]Zhou F, Huang L. Monophosphoryl lipid A enhances specific CTL in-duction by a soluble protein antigen entrapped in liposomes[J]. Vac-cine, 1993,11:1139 被引量:1
  • 2[2]Goyal K, Human L. Gene therapy using DC-Chol cationic liposomes[J]. Liposome Res, 1994,4:1075 被引量:1
  • 3[3]Brunel F, Darbouret A. Cationic lipid DC-Chol induces an improvedand balanced immunity able to overcome the unresponsiveness to thehepatitis B vaccine[J]. Vaccine, 1999,17:2192 被引量:1
  • 4[4]Gao X, Huang L.A novel cationic liposome reagent for efficient tranfec-tion of mammalian cells[ J]. Biochem Biophys Res Commun, 1991,179: 280 被引量:1
  • 5[5]Shahum E, Therien HM. Immunopotentiation of the humoral responseby liposomes:encapsulation versus covalent linkage[J]. Immunology,1998,65:315 被引量:1
  • 6[6]Choi JS, Lee EJ. New cationic liposomes for gene transfer into mam-malian cells with high efficiency and low toxicity[J]. Bioconjug chem,2001,12:108 被引量:1
  • 7[7]Guy B, Pascal N. Design, chatacterization and preclinical efficacy of acationic lipid adjuvant for influenza split vaccine[ J]. Vaccine, 2001,19:1794 被引量:1

同被引文献207

引证文献18

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部